Reproductive BioMedicine Online
Volume 20, Issue 5 , Pages 694-698 , May 2010

Urine neopterin concentrations as a marker for successful blastocyst implantation after assisted reproductive technologies

  • V. Melichar

      Affiliations

    • Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • E. Soelder

      Affiliations

    • Department of Obstetrics and Gynaecology, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • K. Schroecksnadel

      Affiliations

    • Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • C. Murr

      Affiliations

    • Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • P. Arck

      Affiliations

    • Reproductive Immunology Research Group, Department of Internal Medicine, Biomedical Research Center, Campus Virchow, Charité, Berlin, Germany
  • ,
  • L. Wildt

      Affiliations

    • Clinical Department of Endocrinology and Sterility, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • D. Fuchs

      Affiliations

    • Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria
    • Corresponding Author InformationCorresponding author.

Received 16 March 2009 ,Revised 7 July 2009 ,Accepted 21 December 2009.

References 

  1. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 2004;5:266–271
  2. Barrientos G, Fuchs D, Schröcksnadel K, et al. Low levels of serum asymmetric antibodies as a marker of threatened pregnancy. J. Reprod. Immunol. 2009;79:201–210
  3. Bichler A, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Wachter H. Measurement of urinary neopterin in normal pregnant and non-pregnant women with benign and malignant genital tract neoplasms. Arch. Gynecol. 1983;233:121–130
  4. Byrne GI, Lehmann LK, Kirschbaum JG, Borden EC, Lee CM, Brown RR. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J. Interferon Res. 1986;6:389–396
  5. Clark DA. Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure?. J. Assist. Reprod. Genet. 2003;20:63–72
  6. Clark DA, Blois S, Kandil J, Handjiski B, Manuel J, Arck PC. Reduced uterine indoleamine 2,3-dioxygenase versus increased Th1/Th2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am. J. Reprod. Immunol. 2005;54:203–216
  7. Fuchs D, Malkovsky M, Reibnegger G, Werner ER, Forni G, Wachter H. Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol. Lett. 1989;23:103–108
  8. Hanna J, Goldman-Wohl D, Hamani Y, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006;12:1065–1074
  9. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin – release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 1984;160:310–316
  10. Kamimura S, Eguchi K, Yonezawa M, Sekiba K. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med. Okayama. 1991;45:135–139
  11. Karimi K, Blois SM, Arck PC. The upside of natural killers. Nat. Med. 2008;14:1184–1185
  12. Liu Y, Janeway CA. Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp. Med. 1990;172:1735–1739
  13. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Brit. Med. J. 1990;300:230–235
  14. Mellor AL, Munn DH. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J. Reprod. Immunol. 2001;52:5–13
  15. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191–1193
  16. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr. Drug Metab. 2002;3:175–187
  17. Palfi M, Jablonowska B, Matthiesen L, Ernerudh J. Circulating interferon-gamma- and interleukin-4-secreting cells in recurrent spontaneous abortions. Am. J. Reprod. Immunol. 1999;41:257–263
  18. Schroecksnadel K, Fuchs D. Interferon-γ for counteracting T-cell activation. Trends Immunol. 2006;27:398
  19. Schroecksnadel H, Baier-Bitterlich G, Dapunt O, Wachter H, Fuchs D. Decreased plasma tryptophan in pregnancy. Obstet. Gynecol. 1996;88:47–50
  20. Schroecksnadel K, Widner B, Bergant A, et al. Longitudinal study of tryptophan degradation during and after pregnancy. Life Sci. 2003;72:785–793
  21. Schroecksnadel K, Winkler C, Fuchs D. Method for urinary neopterin measurements by HPLC. J. Biochem. Biophys. Methods. 2006;66:99–100
  22. Schroecksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin. Chim. Acta. 2006;364:82–90
  23. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science. 1995;270:630–633
  24. Weiss G, Murr C, Zoller H, et al. Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin. Exp. Immunol. 1999;116:435–440
  25. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Characteristics of interferon induced tryptophan metabolism in human cells in vitro. Biochim. Biophys. Acta. 1989;1012:140–147
  26. Wirleitner B, Reider D, Ebner S, et al. Monocyte-derived dendritic cells release neopterin. J. Leukoc. Biol. 2002;72:1148–1153
  27. Wood KJ, Sawitzki B. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 2006;27:183–187
  28. Yoshida R, Imanishi J, Oku T, Kishida T, Hayaishi O. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc. Natl. Acad. Sci. USA. 1981;78:129–132
  29. Zhou M, Mellor AL. Expanded cohorts of maternal CD8+ T-cells specific for paternal MHC class I accumulate during pregnancy. J. Reprod. Immunol. 1998;40:47–62

 Dietmar Fuchs graduated in chemistry in 1980 from the University of Innsbruck, Austria. After employment at the Institute of Medical Chemistry and Biochemistry, he became Reader in Medical Chemistry (1986), and Associate Professor and co-director of the Ludwig Boltzmann Institute for AIDS-Research at the Medical Faculty. He was Honorary Visiting Fellow (Aston University, Birmingham, UK) and Honorary Senior Research Fellow (University of Birmingham) from 1994–1998. His scientific interests lie in the fields of Clinical Biochemistry and Clinical Immunology focusing on the metabolism of neopterin and tryptophan. He has published 730 articles in peer-reviewed scientific journals and received several national and international awards.

PII: S1472-6483(10)00052-0

doi: 10.1016/j.rbmo.2010.01.016

Reproductive BioMedicine Online
Volume 20, Issue 5 , Pages 694-698 , May 2010